Mergers & AcquisITions
TRANSLATING YOUR CLINICAL RELEVANCE TO SHAREHOLDER VALUE
M&A SELLSIDE
WE DON'T JUST KNOW YOUR BUYERS, WE KNOW WHY THEY BUY
MedDx’s focus on the life science tools and diagnostics industry equips us to lead sale mandates related to a specific business unit, a major division, or in most circumstances the sale of an entire company. Our deep, current relationships with strategic buyers & investors enable us to run a more efficient, focused process leading to a successful outcome.
MedDx advises its clients as to the best selling strategy to be followed (such as broad auction, controlled sale, or highly-confidential sale). Working closely with the our client, MedDx professionals prepare an Information Memorandum which prominently positions the relevant operating, technological, and financial characteristics of the business to be sold. Next, MedDx creates a buyers list of all possible strategic buyers and investors, but ultimately combines our industry expertise with that of our clients to achieve the best outcome for shareholders.
MedDx then discreetly probes buyer interest before revealing the identity of our client and the details of the contemplated transaction. Often times, buyers are contacted in the normal course business at industry events or occasions, not on a one-off basis.
As the process continues, we manage buyer due diligence, from preparing our clients for management presentations, to customizing a data room, to attendance at buyer on-site visits. Throughout the sale process, we advise the client on winnowing out the least committed and least compatible buyers, most often through a multiple-bid process.
Once the process has been narrowed to one buyer, MedDx participates in the negotiations, alongside the client and its legal counsel, in order to ensure that the deal is documented and consummated consistent with the intent of our client.
M&A BUYSIDE
WE KNOW WHERE TO FIND YOUR MISSING PIECE
MedDx’s continual dialogue with key industry thought leaders, and proprietary database, equips us with an important competitive edge compared to other investment banking firms simply offering deal execution capabilities.
MedDx’s proprietary knowledge enables it to originate unique transaction opportunities. As a normal course of business, we often suggest specific targets, markets or technology platforms to a potential client, based on our understanding of the client’s strategic objectives and our in-depth knowledge of the relevant markets, technological or industry sector. Frequently, clients seeks our advice in identifying a suitable acquisition opportunity in a given clinical, geographic or technological area.
Upon identification of the target, MedDx makes an initial approach to the target to make a quick assessment as to the target’s willingness and ability to do a deal at terms that may suit our client. At this stage, our expertise is invaluable as many deals make sense, but we can identify the industry and execution risks that are often insurmountable, saving our clients time and money.